Trials / Terminated
TerminatedNCT03922451
Pharmacokinetics of Antibiotics During Extracorporeal Membrane Oxygenation (ECMO) Support
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 4 (actual)
- Sponsor
- Boston Children's Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study will measure plasma concentrations of piperacillin-tazobactam and cefazolin in pediatric patients supported with extracorporeal membrane oxygenation (ECMO) aiming to better understand the pharmacokinetics of these medications in this in vivo setting.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | piperacillin-tazobactam | Administered for infection treatment or prophylaxis per hospital protocol |
| DRUG | Cefazolin | Administered for infection treatment or prophylaxis per hospital protocol |
Timeline
- Start date
- 2019-08-27
- Primary completion
- 2020-04-01
- Completion
- 2022-02-28
- First posted
- 2019-04-22
- Last updated
- 2022-03-21
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT03922451. Inclusion in this directory is not an endorsement.